Skip to main content
Erschienen in: Clinical Oral Investigations 2/2018

08.07.2017 | Original Article

Influence of bisphosphonates on the adherence and metabolism of epithelial cells and gingival fibroblasts to titanium surfaces

verfasst von: Fernanda Gonçalves Basso, Taisa N. Pansani, Diana G. Soares, Lais M. Cardoso, Josimeri Hebling, Carlos Alberto de Souza Costa

Erschienen in: Clinical Oral Investigations | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To evaluate the effects of sodium alendronate (SA) and zoledronic acid (ZA), on the adhesion and metabolism of epithelial cells and gingival fibroblasts to titanium surfaces considering cell functions related to an effective mucosal barrier around the implant.

Materials and methods

Cells were seeded onto titanium discs and incubated for 24 h. Then, serum-free DMEM containing selected bisphosphonates (0, 0.5, 1, or 5 μM) was added for 24 and 48 h. Factors related to the achievement of an effective mechanical and immunological barrier—cell adhesion, viability, collagen epidermal growth factor, and immunoglobulin synthesis—were evaluated. Data were analyzed by Kruskal-Wallis and Mann-Whitney tests as well as by ANOVA and Tukey’s tests, (α = 0.05).

Results

The presence of bisphosphonates culminated in lower cell adhesion to the titanium discs, particularly for SA at 5 μM (40%) and ZA at all concentrations (from 30 to 50%, according to increased concentrations). Reduced cell viability occurred after exposing these cells to ZA (40%); however, only 5 μM SA-treated cells had decreased viability (30%). Reduced synthesis of growth factors and collagen was observed when cells were reated with ZA (20 and 40%, respectively), while about 70% of IgG synthesis was enhanced.

Conclusion

Bisphosphonates negatively affected the adhesion and metabolism of oral mucosal cells, and this effect was related to the type of bisphosphonate as well as to concentration and period of treatment.

Clinical relevance

The negative effects of bisphosphonates on oral mucosal cells can hamper the formation of an effective biological seal in osseointegrated implants.
Literatur
1.
Zurück zum Zitat Rogers MJ, Gordon S, Benford HL et al (2000) Cellular and molecular mechanisms of action of bisphosphonates. Cancer 88:2961–2978CrossRefPubMed Rogers MJ, Gordon S, Benford HL et al (2000) Cellular and molecular mechanisms of action of bisphosphonates. Cancer 88:2961–2978CrossRefPubMed
3.
Zurück zum Zitat Simon MJK, Niehoff P, Kimming B, Açil Y (2010) Expression profile and synthesis of different collagen types I, II, III and V of human gingiva fibroblasts, osteoblasts, and SaOS-2 cells after bisphosphonate treatment. Clin Oral Invest 14:51–58CrossRef Simon MJK, Niehoff P, Kimming B, Açil Y (2010) Expression profile and synthesis of different collagen types I, II, III and V of human gingiva fibroblasts, osteoblasts, and SaOS-2 cells after bisphosphonate treatment. Clin Oral Invest 14:51–58CrossRef
4.
Zurück zum Zitat Walter C, Klein MO, Pabst A, Al-Nawas B, Duschner H, Ziebart T (2010) Influence of bisphosphonates on endothelial cells, fibroblasts, and osteogenic cells. Clin Oral Invest 14:35–41CrossRef Walter C, Klein MO, Pabst A, Al-Nawas B, Duschner H, Ziebart T (2010) Influence of bisphosphonates on endothelial cells, fibroblasts, and osteogenic cells. Clin Oral Invest 14:35–41CrossRef
5.
Zurück zum Zitat Basso FG, Pansani TN, Oliveira CF et al (2013) Cytotoxic effects of zoledronic acid on human epithelial cells and gingival fibroblasts. Braz Dent J 24:551–558CrossRefPubMed Basso FG, Pansani TN, Oliveira CF et al (2013) Cytotoxic effects of zoledronic acid on human epithelial cells and gingival fibroblasts. Braz Dent J 24:551–558CrossRefPubMed
6.
Zurück zum Zitat Basso FG, Turrioni APS, Hebling J, de Souza Costa CA (2013) Zoledronic acid inhibits human osteoblast activities. Gerontology 59:534–541CrossRefPubMed Basso FG, Turrioni APS, Hebling J, de Souza Costa CA (2013) Zoledronic acid inhibits human osteoblast activities. Gerontology 59:534–541CrossRefPubMed
7.
Zurück zum Zitat Migliorati CA, Casiglia J, Epstein J, Jacobsen PL, Siegel MA, Woo S (2005) Managing the care of patients with bisphosphonate-associated osteonecrosis. JADA 136:1658–1668PubMed Migliorati CA, Casiglia J, Epstein J, Jacobsen PL, Siegel MA, Woo S (2005) Managing the care of patients with bisphosphonate-associated osteonecrosis. JADA 136:1658–1668PubMed
8.
Zurück zum Zitat Woo S, Hellstein JW, Kalmar JR (2006) Systematic review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 144:753–761CrossRefPubMed Woo S, Hellstein JW, Kalmar JR (2006) Systematic review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 144:753–761CrossRefPubMed
9.
Zurück zum Zitat Diel IJ, Fogelman I, Al-Nawas B et al (2007) Pathophysiology, risk factors and management of bisphosphonate-associated osteonecrosis of the jaw: is there a diverse relationship of amino and non-aminobisphosphonates? Crit Rev Oncol Hematol 64:198–207CrossRefPubMed Diel IJ, Fogelman I, Al-Nawas B et al (2007) Pathophysiology, risk factors and management of bisphosphonate-associated osteonecrosis of the jaw: is there a diverse relationship of amino and non-aminobisphosphonates? Crit Rev Oncol Hematol 64:198–207CrossRefPubMed
10.
Zurück zum Zitat Idris AI, Rojas J, Greis IR, van’t Hof RJ, Ralston SH (2008) Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro. Calcif Tissue Int 82:191–201CrossRefPubMed Idris AI, Rojas J, Greis IR, van’t Hof RJ, Ralston SH (2008) Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro. Calcif Tissue Int 82:191–201CrossRefPubMed
11.
Zurück zum Zitat Orriss IR, Key ML, Colston KW, Arnett TR (2008) Inhibition of osteoblast function in vitro by aminobisphosphonates. J Cell Biochem 106:109–118CrossRef Orriss IR, Key ML, Colston KW, Arnett TR (2008) Inhibition of osteoblast function in vitro by aminobisphosphonates. J Cell Biochem 106:109–118CrossRef
12.
Zurück zum Zitat Scheper MA, Badros A, Salama AR et al (2009) A novel bioassay model to determine clinically significant bisphosphonate levels. Support Care Cancer 17:1553–1557CrossRefPubMed Scheper MA, Badros A, Salama AR et al (2009) A novel bioassay model to determine clinically significant bisphosphonate levels. Support Care Cancer 17:1553–1557CrossRefPubMed
13.
Zurück zum Zitat Ravosa MJ, Ning J, Liu Y, Stack S (2011) Bisphosphonate effects on the behavior of oral epithelial cells and oral fibroblasts. Arch Oral Biol 56:491–498CrossRefPubMed Ravosa MJ, Ning J, Liu Y, Stack S (2011) Bisphosphonate effects on the behavior of oral epithelial cells and oral fibroblasts. Arch Oral Biol 56:491–498CrossRefPubMed
14.
Zurück zum Zitat Basso FG, Turrioni APS, Soares DG, Bagnato VS, Hebling J, de Souza Costa CA (2014) Low-level laser therapy for osteonecrotic lesions: effects on osteoblasts treated with zoledronic acid. Support Care Cancer 22:2741–2748CrossRefPubMed Basso FG, Turrioni APS, Soares DG, Bagnato VS, Hebling J, de Souza Costa CA (2014) Low-level laser therapy for osteonecrotic lesions: effects on osteoblasts treated with zoledronic acid. Support Care Cancer 22:2741–2748CrossRefPubMed
15.
Zurück zum Zitat Migliorati CA, Woo S, Hewson I et al (2009) A systematic review of bisphosphonate osteonecroses (BON) in cancer. Support Care Cancer 18:1099–1106CrossRef Migliorati CA, Woo S, Hewson I et al (2009) A systematic review of bisphosphonate osteonecroses (BON) in cancer. Support Care Cancer 18:1099–1106CrossRef
16.
18.
Zurück zum Zitat Otto S, Pautke C, Opelz C et al (2010) Osteonecrosis of the jaw: effect of bisphosphonate type, local concentration, and acidic milieu on the pathomechanism. J Oral Maxillofac Surg 68:2837–2845CrossRefPubMed Otto S, Pautke C, Opelz C et al (2010) Osteonecrosis of the jaw: effect of bisphosphonate type, local concentration, and acidic milieu on the pathomechanism. J Oral Maxillofac Surg 68:2837–2845CrossRefPubMed
19.
Zurück zum Zitat Madrid C, Sanz M (2009) What impact do systemically administered bisphosphonates have on oral implant therapy? A systematic review. Clin Oral Impl Res 20:87–95CrossRef Madrid C, Sanz M (2009) What impact do systemically administered bisphosphonates have on oral implant therapy? A systematic review. Clin Oral Impl Res 20:87–95CrossRef
20.
Zurück zum Zitat Javed F, Almas K (2010) Osseointegration of dental implants in patients undergoing bisphosphonate treatment: a literature review. J Periodontol 81:479–484CrossRefPubMed Javed F, Almas K (2010) Osseointegration of dental implants in patients undergoing bisphosphonate treatment: a literature review. J Periodontol 81:479–484CrossRefPubMed
21.
Zurück zum Zitat Chadha G, Ahmadieh A, Kumar S, Sedghzadeh PP (2013) Osseointegration of dental implants and osteonecrosis of the jaw in patients treated with bisphosphonate therapy: a systematic review. J Oral Implantol 39:510–520CrossRefPubMed Chadha G, Ahmadieh A, Kumar S, Sedghzadeh PP (2013) Osseointegration of dental implants and osteonecrosis of the jaw in patients treated with bisphosphonate therapy: a systematic review. J Oral Implantol 39:510–520CrossRefPubMed
22.
Zurück zum Zitat Taxel P, Ortiz D, Shafer D et al (2014) The relationship between implant stability and bone health markers in post-menopausal women with bisphosphonate exposure. Clin Oral Invest 18:49–57CrossRef Taxel P, Ortiz D, Shafer D et al (2014) The relationship between implant stability and bone health markers in post-menopausal women with bisphosphonate exposure. Clin Oral Invest 18:49–57CrossRef
23.
Zurück zum Zitat An N, Rausch-fan X, Wieland M, Matejka M, Andrukhov O, Schedle A (2012) Initial attachment, subsequent cell proliferation/viability and gene expression of epithelial cells related to attachment and wound healing in response to different titanium surfaces. Dent Mater 28:1207–1214CrossRefPubMed An N, Rausch-fan X, Wieland M, Matejka M, Andrukhov O, Schedle A (2012) Initial attachment, subsequent cell proliferation/viability and gene expression of epithelial cells related to attachment and wound healing in response to different titanium surfaces. Dent Mater 28:1207–1214CrossRefPubMed
24.
Zurück zum Zitat Etminan M, Aminzadeh K, Mathew IR, Brophy JM (2008) Use of oral bisphosphonates and risk of aseptic osteonecrosis: a nested case-control study. J Rheumatol 35:691–695PubMed Etminan M, Aminzadeh K, Mathew IR, Brophy JM (2008) Use of oral bisphosphonates and risk of aseptic osteonecrosis: a nested case-control study. J Rheumatol 35:691–695PubMed
25.
Zurück zum Zitat Khan AA, Sándor GK, Dore E et al (2008) Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw. J Rheumatol 35:1391–1397PubMed Khan AA, Sándor GK, Dore E et al (2008) Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw. J Rheumatol 35:1391–1397PubMed
26.
Zurück zum Zitat Bedogni A, Bettini G, Totola A, Saia G, Nocini PF (2010) Oral bisphosphonate-associated osteonecrosis of the jaw after implant surgey: a case report and literature review. J Oral Maxillofac Surg 68:1662–1666CrossRefPubMed Bedogni A, Bettini G, Totola A, Saia G, Nocini PF (2010) Oral bisphosphonate-associated osteonecrosis of the jaw after implant surgey: a case report and literature review. J Oral Maxillofac Surg 68:1662–1666CrossRefPubMed
27.
Zurück zum Zitat Assael LA (2009) Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies. J Oral Maxillofac Surg 67:35–43CrossRefPubMed Assael LA (2009) Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies. J Oral Maxillofac Surg 67:35–43CrossRefPubMed
28.
Zurück zum Zitat Body JJ, Mancini I (2002) Bisphosphonates for cancer patients: why, how, and when? Support Care Cancer 10:399–407CrossRefPubMed Body JJ, Mancini I (2002) Bisphosphonates for cancer patients: why, how, and when? Support Care Cancer 10:399–407CrossRefPubMed
29.
Zurück zum Zitat Hynes RO (1992) Integrins: versatility, modulation and signaling in cell adhesion. Cell 69:11–25CrossRefPubMed Hynes RO (1992) Integrins: versatility, modulation and signaling in cell adhesion. Cell 69:11–25CrossRefPubMed
30.
Zurück zum Zitat Patidar K, Parwani RN, Wanjari SP (2011) Correlation of salivary and serum IgG, IgA levels wih total protein in oral submucous fibrosis. J Oral Sci 53:97–102CrossRefPubMed Patidar K, Parwani RN, Wanjari SP (2011) Correlation of salivary and serum IgG, IgA levels wih total protein in oral submucous fibrosis. J Oral Sci 53:97–102CrossRefPubMed
31.
Zurück zum Zitat Tilakaratne WM, Klinikowki MF, Saku T, Peters TJ, Warnakulasuriya S (2006) Oral submucous fibrosis: review on aetiology and pathogenesis. Oral Oncol 42:561–568CrossRefPubMed Tilakaratne WM, Klinikowki MF, Saku T, Peters TJ, Warnakulasuriya S (2006) Oral submucous fibrosis: review on aetiology and pathogenesis. Oral Oncol 42:561–568CrossRefPubMed
Metadaten
Titel
Influence of bisphosphonates on the adherence and metabolism of epithelial cells and gingival fibroblasts to titanium surfaces
verfasst von
Fernanda Gonçalves Basso
Taisa N. Pansani
Diana G. Soares
Lais M. Cardoso
Josimeri Hebling
Carlos Alberto de Souza Costa
Publikationsdatum
08.07.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Oral Investigations / Ausgabe 2/2018
Print ISSN: 1432-6981
Elektronische ISSN: 1436-3771
DOI
https://doi.org/10.1007/s00784-017-2167-2

Weitere Artikel der Ausgabe 2/2018

Clinical Oral Investigations 2/2018 Zur Ausgabe

Parodontalbehandlung verbessert Prognose bei Katheterablation

19.04.2024 Vorhofflimmern Nachrichten

Werden Personen mit Vorhofflimmern in der Blanking-Periode nach einer Katheterablation gegen eine bestehende Parodontitis behandelt, verbessert dies die Erfolgsaussichten. Dafür sprechen die Resultate einer prospektiven Untersuchung.

Invasive Zahnbehandlung: Wann eine Antibiotikaprophylaxe vor infektiöser Endokarditis schützt

11.04.2024 Endokarditis Nachrichten

Bei welchen Personen eine Antibiotikaprophylaxe zur Prävention einer infektiösen Endokarditis nach invasiven zahnärztlichen Eingriffen sinnvoll ist, wird diskutiert. Neue Daten stehen im Einklang mit den europäischen Leitlinienempfehlungen.

Zell-Organisatoren unter Druck: Mechanismen des embryonalen Zahnwachstums aufgedeckt

08.04.2024 Zahnmedizin Nachrichten

Der Aufbau von Geweben und Organen während der Embryonalentwicklung wird von den Zellen bemerkenswert choreografiert. Für diesen Prozess braucht es spezielle sogenannte „Organisatoren“. In einer aktuellen Veröffentlichung im Fachjournal Nature Cell Biology berichten Forschende durch welchen Vorgang diese Organisatoren im Gewebe entstehen und wie sie dann die Bildung von Zähnen orchestrieren.

Die Oralprophylaxe & Kinderzahnheilkunde umbenannt

11.03.2024 Kinderzahnmedizin Nachrichten

Infolge der Umbenennung der Deutschen Gesellschaft für Kinderzahnheilkunde in Deutsche Gesellschaft für Kinderzahnmedizin (DGKiZ) wird deren Mitgliederzeitschrift Oralprophylaxe & Kinderzahnheilkunde in Oralprophylaxe & Kinderzahnmedizin umbenannt. Aus diesem Grunde trägt die erste Ausgabe in 2024 erstmalig den neuen Titel.

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Zahnmedizin und bleiben Sie gut informiert – ganz bequem per eMail.